Jason R. Cannon, PhD - Publications

Affiliations: 
Purdue University, West Lafayette, IN, United States 

60 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Currim F, Shukla S, Singh J, Gohel D, Mane M, Shinde A, Roy M, Goyani S, Vasiyani H, Chandran A, Rochet JC, Cannon J, Singh R. Neuronal exosomal miRNAs modulate mitochondrial functions and cell death in bystander neuronal cells under Parkinson's disease stress conditions. Neurotoxicology. 101: 102-116. PMID 38401688 DOI: 10.1016/j.neuro.2024.02.005  0.586
2023 Fernandez RF, Wilson ES, Diaz V, Martínez-Gardeazabal J, Foguth R, Cannon JR, Jackson SN, Hermann BP, Eells JB, Ellis JM. Lipid metabolism in dopaminergic neurons influences light entrainment. Journal of Neurochemistry. PMID 36815399 DOI: 10.1111/jnc.15793  0.788
2022 Sammi SR, Syeda T, Conrow KD, Leung MCK, Cannon JR. Complementary biological and computational approaches identify distinct mechanisms of chlorpyrifos versus chlorpyrifos oxon induced dopaminergic neurotoxicity. Toxicological Sciences : An Official Journal of the Society of Toxicology. PMID 36269219 DOI: 10.1093/toxsci/kfac114  0.755
2022 Brown-Leung JM, Cannon JR. Neurotransmission Targets of Per- and Polyfluoroalkyl Substance Neurotoxicity: Mechanisms and Potential Implications for Adverse Neurological Outcomes. Chemical Research in Toxicology. 35: 1312-1333. PMID 35921496 DOI: 10.1021/acs.chemrestox.2c00072  0.327
2022 Sammi SR, Jameson LE, Conrow KD, Leung MCK, Cannon JR. Neurotoxicity Testing: Novel Applications in the Adverse Outcome Pathway Framework. Frontiers in Toxicology. 4: 826488. PMID 35373186 DOI: 10.3389/ftox.2022.826488  0.73
2022 Syeda T, Cannon JR. Potential Role of Heterocyclic Aromatic Amines in Neurodegeneration. Chemical Research in Toxicology. 35: 59-72. PMID 34990108 DOI: 10.1021/acs.chemrestox.1c00274  0.359
2021 Adamson SX, Zheng W, Agim ZS, Du S, Fleming S, Shannahan J, Cannon J. Systemic Copper Disorders Influence the Olfactory Function in Adult Rats: Roles of Altered Adult Neurogenesis and Neurochemical Imbalance. Biomolecules. 11. PMID 34572528 DOI: 10.3390/biom11091315  0.741
2021 Syeda T, Cannon JR. Environmental exposures and the etiopathogenesis of Alzheimer's disease: The potential role of BACE1 as a critical neurotoxic target. Journal of Biochemical and Molecular Toxicology. e22694. PMID 33393683 DOI: 10.1002/jbt.22694  0.774
2020 Lawana V, Um SY, Foguth RM, Cannon JR. Neuromelanin formation exacerbates HAA-induced mitochondrial toxicity and mitophagy impairments. Neurotoxicology. 81: 147-160. PMID 33058929 DOI: 10.1016/j.neuro.2020.10.005  0.826
2020 Foguth RM, Hoskins TD, Clark GC, Nelson M, Flynn RW, de Perre C, Hoverman JT, Lee LS, Sepúlveda MS, Cannon JR. Single and mixture per- and polyfluoroalkyl substances accumulate in developing Northern leopard frog brains and produce complex neurotransmission alterations. Neurotoxicology and Teratology. 106907. PMID 32561179 DOI: 10.1016/J.Ntt.2020.106907  0.765
2020 Foguth R, Sepúlveda MS, Cannon J. Per- and Polyfluoroalkyl Substances (PFAS) Neurotoxicity in Sentinel and Non-Traditional Laboratory Model Systems: Potential Utility in Predicting Adverse Outcomes in Human Health. Toxics. 8. PMID 32549216 DOI: 10.3390/Toxics8020042  0.761
2020 Syeda T, Foguth RM, Llewellyn E, Cannon JR. PhIP exposure in rodents produces neuropathology potentially relevant to Alzheimer's disease. Toxicology. 152436. PMID 32169473 DOI: 10.1016/J.Tox.2020.152436  0.758
2020 Bentz BZ, Mahalingam SM, Ysselstein D, Montenegro PC, Cannon JR, Rochet JC, Low PS, Webb KJ. Localization of fluorescent targets in deep tissue with expanded beam illumination for studies of cancer and the brain. Ieee Transactions On Medical Imaging. PMID 32031935 DOI: 10.1109/Tmi.2020.2972200  0.521
2019 Lawana V, Um SY, Rochet JC, Turesky RJ, Shannahan JH, Cannon JR. Neuromelanin modulates heterocyclic aromatic amine-induced dopaminergic neurotoxicity. Toxicological Sciences : An Official Journal of the Society of Toxicology. PMID 31562763 DOI: 10.1093/Toxsci/Kfz210  0.672
2019 Patel SH, Yue F, Saw SK, Foguth R, Cannon JR, Shannahan JH, Kuang S, Sabbaghi A, Carroll CC. Advanced Glycation End-Products Suppress Mitochondrial Function and Proliferative Capacity of Achilles Tendon-Derived Fibroblasts. Scientific Reports. 9: 12614. PMID 31471548 DOI: 10.1038/S41598-019-49062-8  0.759
2019 Raj Sammi S, Foguth RM, Sofiá Nieves C, De Perre C, Wipf P, McMurray CT, Lee LS, Cannon JR. Perfluorooctane sulfonate (PFOS) produces dopaminergic neuropathology in C. elegans. Toxicological Sciences : An Official Journal of the Society of Toxicology. PMID 31428778 DOI: 10.1093/Toxsci/Kfz191  0.815
2019 Foguth RM, Flynn RW, de Perre C, Iacchetta M, Lee LS, Sepúlveda MS, Cannon JR. Developmental exposure to perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) selectively decreases brain dopamine levels in northern leopard frogs. Toxicology and Applied Pharmacology. 114623. PMID 31195004 DOI: 10.1016/J.Taap.2019.114623  0.789
2019 Sanyal A, Dutta S, Camara A, Chandran A, Koller A, Watson BG, Sengupta R, Ysselstein D, Montenegro P, Cannon J, Rochet JC, Mattoo S. Alpha-Synuclein Is a Target of Fic-Mediated Adenylylation/AMPylation: Possible Implications for Parkinson's Disease. Journal of Molecular Biology. PMID 31034889 DOI: 10.1016/J.Jmb.2019.04.026  0.594
2018 Fernandez RF, Kim SQ, Zhao Y, Foguth RM, Weera MM, Counihan JL, Nomura DK, Chester JA, Cannon JR, Ellis JM. Acyl-CoA synthetase 6 enriches the neuroprotective omega-3 fatty acid DHA in the brain. Proceedings of the National Academy of Sciences of the United States of America. PMID 30401738 DOI: 10.1073/Pnas.1807958115  0.764
2018 Weera MM, Agim ZS, Cannon JR, Chester JA. Genetic correlations between nicotine Reinforcement-Related behaviors and propensity toward high or low alcohol preference in two replicate mouse lines. Genes, Brain, and Behavior. e12515. PMID 30129253 DOI: 10.1111/Gbb.12515  0.751
2018 Wise JP, Price CG, Amaro JA, Cannon JR. Autophagy Disruptions Associated With Altered Optineurin Expression in Extranigral Regions in a Rotenone Model of Parkinson's Disease. Frontiers in Neuroscience. 12: 289. PMID 29867311 DOI: 10.3389/Fnins.2018.00289  0.479
2018 Adamson SX, Shen X, Jiang W, Lai V, Wang X, Shannahan JH, Cannon JR, Chen J, Zheng W. Subchronic manganese exposure impairs neurogenesis in the adult rat hippocampus. Toxicological Sciences : An Official Journal of the Society of Toxicology. PMID 29579278 DOI: 10.1093/Toxsci/Kfy062  0.341
2018 Cruz-Hernandez A, Agim ZS, Montenegro PC, McCabe GP, Rochet JC, Cannon JR. Selective dopaminergic neurotoxicity of three heterocyclic amine subclasses in primary rat midbrain neurons. Neurotoxicology. PMID 29408373 DOI: 10.1016/J.Neuro.2018.01.009  0.806
2018 Agim ZS, Cannon JR. Alterations in the nigrostriatal dopamine system after acute systemic PhIP exposure. Toxicology Letters. 287: 31-41. PMID 29378243 DOI: 10.1016/J.Toxlet.2018.01.017  0.82
2017 Sammi SR, Agim ZS, Cannon JR. Harmane-induced selective dopaminergic neurotoxicity in C. elegans. Toxicological Sciences : An Official Journal of the Society of Toxicology. PMID 29069497 DOI: 10.1093/Toxsci/Kfx223  0.814
2017 Park J, Lee JW, Cooper SC, Broxmeyer HE, Cannon JR, Kim CH. Parkinson disease-associated LRRK2 G2019S transgene disrupts marrow myelopoiesis and peripheral Th17 response. Journal of Leukocyte Biology. PMID 28751472 DOI: 10.1189/Jlb.1A0417-147Rr  0.469
2016 Wise JP, Cannon J. Alterations in Optineurin Expression and Localization in Pre-clinical Parkinson's Disease Models. Toxicological Sciences : An Official Journal of the Society of Toxicology. PMID 27473339 DOI: 10.1093/Toxsci/Kfw133  0.476
2016 Dukes AA, Bai Q, Van Laar VS, Zhou Y, Ilin V, David CN, Agim ZS, Bonkowsky JL, Cannon JR, Watkins SC, Croix CM, Burton EA, Berman SB. Live imaging of mitochondrial dynamics in CNS dopaminergic neurons in vivo demonstrates early reversal of mitochondrial transport following MPP(+) exposure. Neurobiology of Disease. PMID 27452482 DOI: 10.1016/J.Nbd.2016.07.020  0.809
2016 Fu S, Jiang W, Gao X, Zeng A, Cholger D, Cannon J, Chen J, Zheng W. Aberrant adult Neurogenesis in the subventricular zone-rostral migratory stream-olfactory bulb system following subchronic manganese exposure. Toxicological Sciences : An Official Journal of the Society of Toxicology. PMID 26794142 DOI: 10.1093/Toxsci/Kfw007  0.301
2016 Agim Z, Cannon J. Dopaminergic neurotoxicity of PHIP in vivo Toxicology Letters. 259: S199. DOI: 10.1016/J.Toxlet.2016.07.475  0.803
2016 Agim Z, Jacquet A, Rochet J, Cannon J. Mechanism of PHIP-induced dopaminergic neurotoxicicty in primary midbrain cultures Toxicology Letters. 259: S198-S199. DOI: 10.1016/J.Toxlet.2016.07.474  0.758
2015 Zharikov AD, Cannon JR, Tapias V, Bai Q, Horowitz MP, Shah V, El Ayadi A, Hastings TG, Greenamyre JT, Burton EA. shRNA targeting α-synuclein prevents neurodegeneration in a Parkinson's disease model. The Journal of Clinical Investigation. PMID 26075822 DOI: 10.1172/Jci64502  0.789
2015 Wirbisky SE, Weber GJ, Sepúlveda MS, Xiao C, Cannon JR, Freeman JL. Developmental origins of neurotransmitter and transcriptome alterations in adult female zebrafish exposed to atrazine during embryogenesis. Toxicology. 333: 156-67. PMID 25929836 DOI: 10.1016/J.Tox.2015.04.016  0.582
2015 Lee JW, Cannon JR. LRRK2 mutations and neurotoxicant susceptibility. Experimental Biology and Medicine (Maywood, N.J.). 240: 752-9. PMID 25888648 DOI: 10.1177/1535370215579162  0.515
2015 Robison G, Sullivan B, Cannon JR, Pushkar Y. Identification of dopaminergic neurons of the substantia nigra pars compacta as a target of manganese accumulation. Metallomics : Integrated Biometal Science. 7: 748-55. PMID 25695229 DOI: 10.1039/C5Mt00023H  0.382
2015 Agim ZS, Cannon JR. Dietary factors in the etiology of Parkinson's disease. Biomed Research International. 2015: 672838. PMID 25688361 DOI: 10.1155/2015/672838  0.8
2015 Lee JW, Tapias V, Di Maio R, Greenamyre JT, Cannon JR. Behavioral, neurochemical, and pathologic alterations in bacterial artificial chromosome transgenic G2019S leucine-rich repeated kinase 2 rats. Neurobiology of Aging. 36: 505-18. PMID 25174649 DOI: 10.1016/J.Neurobiolaging.2014.07.011  0.677
2014 O'Neal SL, Lee JW, Zheng W, Cannon JR. Subacute manganese exposure in rats is a neurochemical model of early manganese toxicity. Neurotoxicology. 44: 303-13. PMID 25117542 DOI: 10.1016/J.Neuro.2014.08.001  0.538
2014 Wirbisky SE, Weber GJ, Lee JW, Cannon JR, Freeman JL. Novel dose-dependent alterations in excitatory GABA during embryonic development associated with lead (Pb) neurotoxicity. Toxicology Letters. 229: 1-8. PMID 24875535 DOI: 10.1016/J.Toxlet.2014.05.016  0.452
2014 Griggs AM, Agim ZS, Mishra VR, Tambe MA, Director-Myska AE, Turteltaub KW, McCabe GP, Rochet JC, Cannon JR. 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) is selectively toxic to primary dopaminergic neurons in vitro. Toxicological Sciences : An Official Journal of the Society of Toxicology. 140: 179-89. PMID 24718704 DOI: 10.1093/Toxsci/Kfu060  0.816
2014 Tapias V, Cannon JR, Greenamyre JT. Pomegranate juice exacerbates oxidative stress and nigrostriatal degeneration in Parkinson's disease. Neurobiology of Aging. 35: 1162-76. PMID 24315037 DOI: 10.1016/J.Neurobiolaging.2013.10.077  0.661
2014 Wang Y, Lee JW, Oh G, Grady SR, McIntosh JM, Brunzell DH, Cannon JR, Drenan RM. Enhanced synthesis and release of dopamine in transgenic mice with gain-of-function α6* nAChRs. Journal of Neurochemistry. 129: 315-27. PMID 24266758 DOI: 10.1111/Jnc.12616  0.472
2013 Cannon JR, Geghman KD, Tapias V, Sew T, Dail MK, Li C, Greenamyre JT. Expression of human E46K-mutated α-synuclein in BAC-transgenic rats replicates early-stage Parkinson's disease features and enhances vulnerability to mitochondrial impairment. Experimental Neurology. 240: 44-56. PMID 23153578 DOI: 10.1016/J.Expneurol.2012.11.007  0.656
2013 Cannon JR, Greenamyre JT. Gene-environment interactions in Parkinson's disease: specific evidence in humans and mammalian models. Neurobiology of Disease. 57: 38-46. PMID 22776331 DOI: 10.1016/J.Nbd.2012.06.025  0.612
2013 Greenamyre JT, Cannon JR, Sanders LH, Tapias V, Bai Q, Volpicelli-Daley L, Lee VM, Burton EA. Synuclein-Mitochondrial Interactions in Substantia Nigra Dopamine Neurons Catecholamine Research in the 21st Century: Abstracts and Graphical Abstracts, 10th International Catecholamine Symposium, 2012. 126-127. DOI: 10.1016/B978-0-12-800044-1.00111-2  0.75
2012 Milanese C, Sager JJ, Bai Q, Farrell TC, Cannon JR, Greenamyre JT, Burton EA. Hypokinesia and reduced dopamine levels in zebrafish lacking β- and γ1-synucleins. The Journal of Biological Chemistry. 287: 2971-83. PMID 22128150 DOI: 10.1074/Jbc.M111.308312  0.639
2011 Cannon JR, Greenamyre JT. The role of environmental exposures in neurodegeneration and neurodegenerative diseases. Toxicological Sciences : An Official Journal of the Society of Toxicology. 124: 225-50. PMID 21914720 DOI: 10.1093/Toxsci/Kfr239  0.601
2011 Cannon JR, Sew T, Montero L, Burton EA, Greenamyre JT. Pseudotype-dependent lentiviral transduction of astrocytes or neurons in the rat substantia nigra. Experimental Neurology. 228: 41-52. PMID 21056560 DOI: 10.1016/J.Expneurol.2010.10.016  0.569
2010 Cannon JR, Greenamyre JT. Neurotoxic in vivo models of Parkinson's disease recent advances. Progress in Brain Research. 184: 17-33. PMID 20887868 DOI: 10.1016/S0079-6123(10)84002-6  0.608
2010 Greenamyre JT, Cannon JR, Drolet R, Mastroberardino PG. Lessons from the rotenone model of Parkinson's disease. Trends in Pharmacological Sciences. 31: 141-2; author reply . PMID 20096940 DOI: 10.1016/J.Tips.2009.12.006  0.82
2010 Tapias V, Cannon JR, Greenamyre JT. Melatonin treatment potentiates neurodegeneration in a rat rotenone Parkinson's disease model. Journal of Neuroscience Research. 88: 420-7. PMID 19681169 DOI: 10.1002/Jnr.22201  0.664
2009 Cannon JR, Greenamyre JT. NeuN is not a reliable marker of dopamine neurons in rat substantia nigra. Neuroscience Letters. 464: 14-7. PMID 19682546 DOI: 10.1016/J.Neulet.2009.08.023  0.601
2009 Drolet RE, Cannon JR, Montero L, Greenamyre JT. Chronic rotenone exposure reproduces Parkinson's disease gastrointestinal neuropathology. Neurobiology of Disease. 36: 96-102. PMID 19595768 DOI: 10.1016/J.Nbd.2009.06.017  0.749
2009 Cannon JR, Tapias V, Na HM, Honick AS, Drolet RE, Greenamyre JT. A highly reproducible rotenone model of Parkinson's disease. Neurobiology of Disease. 34: 279-90. PMID 19385059 DOI: 10.1016/J.Nbd.2009.01.016  0.762
2009 Drolet RE, Cannon JR, Montero LM, Greenamyre JT. T1782 Rotenone Recapitulates Parkinson's Disease-Related Gastrointestinal Motility Deficits and Alpha-Synuclein Pathology in the Enteric Nervous System Gastroenterology. 136: A-578-A-579. DOI: 10.1016/S0016-5085(09)62663-9  0.698
2007 Cannon JR, Xi G, Keep RF. Recent research on changes in genomic regulation and protein expression in intracerebral haemorrhage. International Journal of Stroke : Official Journal of the International Stroke Society. 2: 265-9. PMID 18705926 DOI: 10.1111/J.1747-4949.2007.00160.X  0.454
2007 Cannon JR, Hua Y, Richardson RJ, Xi G, Keep RF, Schallert T. The effect of thrombin on a 6-hydroxydopamine model of Parkinson's disease depends on timing. Behavioural Brain Research. 183: 161-8. PMID 17629581 DOI: 10.1016/J.Bbr.2007.06.004  0.603
2006 Cannon JR, Keep RF, Schallert T, Hua Y, Richardson RJ, Xi G. Protease-activated receptor-1 mediates protection elicited by thrombin preconditioning in a rat 6-hydroxydopamine model of Parkinson's disease. Brain Research. 1116: 177-86. PMID 16934779 DOI: 10.1016/J.Brainres.2006.07.094  0.553
2006 Cannon JR, Nakamura T, Keep RF, Richardson RJ, Hua Y, Xi G. Dopamine changes in a rat model of intracerebral hemorrhage. Acta Neurochirurgica. Supplement. 96: 222-6. PMID 16671459 DOI: 10.1007/3-211-30714-1_48  0.52
2005 Cannon JR, Keep RF, Hua Y, Richardson RJ, Schallert T, Xi G. Thrombin preconditioning provides protection in a 6-hydroxydopamine Parkinson's disease model. Neuroscience Letters. 373: 189-94. PMID 15619541 DOI: 10.1016/J.Neulet.2004.10.089  0.579
Show low-probability matches.